Inventor · disambiguated record
Jeff Sperinde
Also filed as: SPERINDE JEFF
11 granted patents·6 pending applications·90 citations·filing 2005–2022
89Inventor score
Technology areasG01N
Files withLABORATORY CORP AMERICA HOLDINGS7LAB CORP AMERICA HOLDINGS6HUANG WEIDONG2MOORE SEAN C1SPERINDE JEFF1
Top patents by PatentIndex Score
17 records- 0195US8349574B2Methods of determining patient response by measurement of Her-3LAB CORP AMERICA HOLDINGS·Filed 2010·Granted Jan 8, 2013·42 cites·51 claims
- 0288US9766242B2Methods of determining patient response by measurement of HER-3 and P95LABORATORY CORP AMERICA HOLDINGS·Filed 2015·Granted Sep 19, 2017·3 cites·14 claims
- 0386US7939267B2Detection of activation of endothelial cells as surrogate marker for angiogenesisLAB CORP AMERICA HOLDINGS·Filed 2005·Granted May 10, 2011·18 cites·19 claims
- 0485US9110066B2HER-3 antibodies and methods of useLAB CORP AMERICA HOLDINGS·Filed 2012·Granted Aug 18, 2015·4 cites·34 claims
- 0584US8470542B2Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95SPERINDE JEFF·Filed 2009·Granted Jun 25, 2013·14 cites·28 claims
- 0681US9081019B2Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95LAB CORP AMERICA HOLDINGS·Filed 2013·Granted Jul 14, 2015·3 cites·6 claims
- 0777US10416162B2Her2 diagnostic methodsHUANG WEIDONG·Filed 2008·Granted Sep 17, 2019·6 cites·21 claims
- 0871US2023062274A1Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer PatientsLABORATORY CORP AMERICA HOLDINGS·Filed 2022·Application pending·0 cites
- 0965US10775382B2Methods of determining patient response by measurement of HER-3LABORATORY CORP AMERICA HOLDINGS·Filed 2017·Granted Sep 15, 2020·0 cites·22 claims
- 1062US11401344B2Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patientsLABORATORY CORP AMERICA HOLDINGS·Filed 2018·Granted Aug 2, 2022·0 cites·11 claims
- 1161US11579148B2Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patientsLABORATORY CORP AMERICA HOLDINGS·Filed 2018·Granted Feb 14, 2023·0 cites·8 claims
- 1260US2014370523A1Methods of Determining Patient Response by Measurement of HER-2 ExpressionLAB CORP AMERICA HOLDINGS·Filed 2014·Application pending·0 cites
- 1358US10273308B2Methods of producing antibodies specific for p95LABORATORY CORP AMERICA HOLDINGS·Filed 2015·Granted Apr 30, 2019·0 cites·3 claims
- 1458US2017082626A1Methods of Determining Patient Response by Measurement of HER-2 ExpressionLABORATORY CORP AMERICA HOLDINGS·Filed 2016·Application pending·0 cites
- 1551US2012295259A1Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer PatientsHUANG WEIDONG·Filed 2012·Application pending·0 cites
- 1650US2010233732A1Methods of Determining Patient Response By Measurement of HER-2 ExpressionLAB CORP AMERICA HOLDINGS·Filed 2010·Application pending·0 cites
- 1745US2011275096A1Detection of Activation of Endothelial Cells as Surrogate Marker for AngiogenesisMOORE SEAN C·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeff Sperinde files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →